Study: Long-term aspirin use may lower colon cancer risk

02/4/2008 | NYTimes.com

An 18-year study involving 47,000 men revealed that the risk of colon cancer is lower in those who took aspirin for more than five years. The study found that men who took more than two 325-mg aspirins a week decreased their cancer risk by about 21%, while those who took six to 14 aspirins weekly cut down their risk by 28%. Men who took more than 14 pills a week reduced their cancer risk by 70%.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA